Xtandi is a revolutionary new drug that has been approved to treat certain types of advanced prostate cancer. Developed by two of the world’s leading pharmaceutical companies, Xtandi is designed to extend the lives of those affected by this terrible disease. In this article, we will answer the question: Who makes Xtandi? We will look at the history of the drug, the collaboration between the two companies, and the impact Xtandi has had on the lives of those affected by prostate cancer. So, if you are wondering who makes Xtandi and how this drug has changed the lives of many, read on to find out!
Xtandi (enzalutamide) is a prescription medication for the treatment of metastatic castration-resistant prostate cancer (mCRPC). It is manufactured and marketed by Astellas Pharma, a global pharmaceutical company headquartered in Tokyo, Japan.
Who Makes Xtandi?
Xtandi is a prescription medication used to treat prostate cancer. It is a new type of drug known as an androgen receptor inhibitor. The drug was initially developed by Astellas Pharma Inc., a Japanese pharmaceutical company, in collaboration with the University of Tokyo. Astellas then entered into a partnership with Medivation, Inc., an American biopharmaceutical company, in 2009 to bring the medication to market.
Development of Xtandi
In 2009, Astellas and Medivation entered into an agreement to develop and commercialize Xtandi. Astellas was responsible for the research, development, manufacturing, and distribution of the medication in Japan, while Medivation took the lead on development and commercialization in the United States.
The U.S. Food and Drug Administration (FDA) approved Xtandi in 2012 for the treatment of castration-resistant prostate cancer, and it is currently marketed by Medivation in the United States. Astellas and Medivation also collaborated to secure approval for Xtandi in the European Union, Canada, and other countries.
Manufacturing of Xtandi
Xtandi is manufactured by Astellas Pharma Inc. in Japan. The medication is produced in a state-of-the-art manufacturing facility located in the city of Tsukuba, Ibaraki Prefecture. The facility is ISO 9001 and ISO 14001 certified, meaning it meets the highest standards of quality and safety.
Distribution of Xtandi
In the United States, Xtandi is distributed by Medivation and its partners. Medivation is responsible for marketing and sales, while its partners are responsible for the distribution of the medication.
In other countries, Xtandi is distributed by Astellas and its partners. Astellas is responsible for research, development, and manufacturing, as well as marketing and sales, while its partners are responsible for distribution.
Frequently Asked Questions
Who Makes Xtandi?
Answer: Xtandi (enzalutamide) is manufactured by Astellas Pharma US, Inc., a biopharmaceutical company dedicated to improving the health and lives of people around the world. Astellas has a strong commitment to research and development and has developed a range of products and treatments, including Xtandi, to treat a variety of conditions.
What is Xtandi Used to Treat?
Answer: Xtandi is a prescription medication used to treat advanced prostate cancer. It is used in combination with another type of hormonal therapy, called a gonadotropin-releasing hormone, or GnRH, agonist, and is used to help slow the rate of cancer growth. In some cases, Xtandi may be used as the only treatment for advanced prostate cancer.
How Does Xtandi Work?
Answer: Xtandi works by blocking the activity of an enzyme called androgen receptor (AR) which is responsible for the growth and spread of prostate cancer. By blocking this enzyme, Xtandi helps to stop the growth and spread of cancer cells. It also works by reducing the levels of androgens, which are male hormones, in the body. This helps to reduce the growth and spread of prostate cancer cells.
What are the Side Effects of Xtandi?
Answer: Xtandi can cause some side effects, including fatigue, nausea, vomiting, diarrhea, constipation, decreased appetite, and weight loss. Other common side effects may include headache, dizziness, depression, anxiety, and insomnia. In some cases, more serious side effects may occur, such as liver problems, seizures, and allergic reactions. It is important to talk to your doctor about any side effects that you experience.
Who Should Not Take Xtandi?
Answer: Xtandi is not recommended for use in women and children. It is also not recommended for people with certain medical conditions, including severe liver or kidney problems, and certain allergies. People taking certain medications, including warfarin, should not take Xtandi. People who have had a stroke or heart attack should also not take Xtandi. Talk to your doctor before taking Xtandi to make sure it is safe for you.
What Should I Do If I Miss a Dose of Xtandi?
Answer: If you miss a dose of Xtandi, take it as soon as you remember. If it is close to the time for your next dose, skip the missed dose and take your next dose at the regular time. Do not take two doses at the same time or take more than the recommended dose. If you have any questions about your dose or how to take Xtandi, talk to your doctor or pharmacist.
Xtandi is a revolutionary new medicine that has been shown to be highly effective in treating prostate cancer. Developed by Astellas Pharma and Medivation, Inc., Xtandi is a medication that has been making waves in the medical community for its efficacy and safety. With its unique formulation, Xtandi has been able to provide patients with a powerful and safe alternative to existing prostate cancer treatments. Xtandi has revolutionized the way prostate cancer is treated and has the potential to save countless lives. Astellas Pharma and Medivation, Inc. are proud to provide the world with Xtandi, a revolutionary new medication that is changing the face of prostate cancer treatment.